A randomized trial for the treatment of refractory status epilepticus

Neurocritical Care

Volumn 14, Issue 1, 2011, Pages 4-10

  Rossetti, Andrea O ^d   Milligan, Tracey A ^a   Vulliémoz, Serge ^b   Michaelides, Costas ^a   Bertschi, Manuel ^c   Lee, Jong Woo ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HUG   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d NONE

Author keywords

Burst suppression; Complications; Outcome; Pentobarbital; Propofol; Thiopental

Indexed keywords

ANTIBIOTIC AGENT; CLONAZEPAM; ETIRACETAM; LAMOTRIGINE; LORAZEPAM; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PROPOFOL; THIOPENTAL; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEMALE; HEALTH SURVEY; HUMAN; HYPOTENSION; ILEUS; INFECTION; INTESTINE ISCHEMIA; LOW DRUG DOSE; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; THROMBOEMBOLISM;

EID: 79551523650     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-010-9445-z     Document Type: Article

References (26)

1. J Novy G Logroscino AO Rossetti 2010 Refractory status epilepticus: a prospective observational study Epilepsia 51 2 251 256 10.1111/j.1528-1167.2009. 02323.x 19817823
2. M Holtkamp J Othman K Buchheim H Meierkord 2005 Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit J Neurol Neurosurg Psychiatry 76 4 534 539 1:STN:280:DC%2BD2M7ktleksg%3D%3D 10.1136/jnnp.2004.041947 15774441 (Pubitemid 40486579)
3. SA Mayer J Claassen J Lokin F Mendelsohn LJ Dennis BF Fitzsimmons 2002 Refractory status epilepticus: frequency, risk factors, and impact on outcome Arch Neurol 59 2 205 210 10.1001/archneur.59.2.205 11843690
4. AO Rossetti G Logroscino EB Bromfield 2005 Refractory status epilepticus: effect of treatment aggressiveness on prognosis Arch Neurol 62 11 1698 1702 10.1001/archneur.62.11.1698 16286542 (Pubitemid 41626665)
5. D Treiman N Walton J Collins 1999 Treatment of status epilepticus if first drug fails Epilepsia 40 Suppl. 7 243
6. DH Lowenstein BK Alldredge 1998 Status epilepticus N Engl J Med 338 14 970 976 1:STN:280:DyaK1c7nt12lsw%3D%3D 10.1056/NEJM199804023381407 9521986 (Pubitemid 28152839)
7. H Meierkord P Boon B Engelsen, et al. 2010 EFNS guideline on the management of status epilepticus in adults Eur J Neurol 17 3 348 355 1:STN:280:DC%2BC3czitlyltw%3D%3D 10.1111/j.1468-1331.2009.02917.x 20050893
8. J Claassen LJ Hirsch RG Emerson SA Mayer 2002 Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review Epilepsia 43 2 146 153 1:CAS:528:DC%2BD38XjtVGktrw%3D 10.1046/j.1528-1157.2002.28501.x 11903460
9. NF Schor JJ Riviello Jr 2005 Treatment with propofol: the new status quo for status epilepticus? Neurology 65 4 506 507 10.1212/01.wnl.0000173427.22021. 9d 16116104 (Pubitemid 41170703)
10. M Holtkamp 2007 The anaesthetic and intensive care of status epilepticus Curr Opin Neurol 20 2 188 193 1:CAS:528:DC%2BD2sXkvFegtrk%3D 10.1097/WCO.0b013e328042bacb 17351490 (Pubitemid 46411505)
11. TP Bleck 2005 Refractory status epilepticus Curr Opin Crit Care 11 2 117 120 10.1097/01.ccx.0000157079.72999.87 15758590 (Pubitemid 40488609)
12. J Claassen LJ Hirsch SA Mayer 2003 Treatment of status epilepticus: a survey of neurologists J Neurol Sci 211 1-2 37 41 12767495
13. M Holtkamp F Masuhr L Harms KM Einhaupl H Meierkord K Buchheim 2003 The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists J Neurol Neurosurg Psychiatry 74 8 1095 1099 1:STN:280:DC%2BD3szksVaitw%3D%3D 10.1136/jnnp.74.8.1095 12876241 (Pubitemid 36936387)
14. AO Rossetti G Logroscino TA Milligan C Michaelides C Ruffieux EB Bromfield 2008 Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy J Neurol 255 10 1561 1566 10.1007/s00415-008-0989-1 18769858
15. AO Rossetti MD Reichhart MD Schaller PA Despland J Bogousslavsky 2004 Propofol treatment of refractory status epilepticus: a study of 31 episodes Epilepsia 45 7 757 763 1:CAS:528:DC%2BD2cXmsVSnsrw%3D 10.1111/j.0013-9580.2004. 01904.x 15230698 (Pubitemid 38890973)
16. B Vasile F Rasulo A Candiani N Latronico 2003 The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome Intensive Care Med 29 9 1417 1425 10.1007/s00134-003-1905-x 12904852 (Pubitemid 37153585)
17. Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League against Epilepsy. Epilepsia 1993; 34(4):592-6.
18. C Cereda MM Berger AO Rossetti 2009 Bowel ischemia: a rare complication of thiopental treatment for status epilepticus Neurocrit Care 10 3 355 358 10.1007/s12028-008-9168-6 19034699
19. MM Stecker TH Kramer EC Raps R O'Meeghan E Dulaney DJ Skaar 1998 Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings Epilepsia 39 1 18 26 1:CAS:528:DyaK1cXnsFWltA%3D%3D 10.1111/j.1528-1157.1998.tb01269.x 9578008 (Pubitemid 28116837)
20. A Wessen PM Persson A Nilsson P Hartvig 1994 Clinical pharmacokinetics of propofol given as a constant-rate infusion and in combination with epidural blockade J Clin Anesth 6 3 193 198 1:STN:280:DyaK2czjvVOjug%3D%3D 10.1016/0952-8180(94)90058-2 7914736 (Pubitemid 24174573)
21. CD Bayliff ML Schwartz BG Hardy 1985 Pharmacokinetics of high-dose pentobarbital in severe head trauma Clin Pharmacol Ther 38 4 457 461 1:STN:280:DyaL28%2FgtlWrsQ%3D%3D 10.1038/clpt.1985.204 4042529
22. DJ Cordato LE Mather AS Gross GK Herkes 1999 Pharmacokinetics of thiopental enantiomers during and following prolonged high-dose therapy Anesthesiology 91 6 1693 1702 1:CAS:528:DC%2BD3cXivFKgtg%3D%3D 10.1097/00000542-199912000-00022 10598612
23. I Parviainen A Uusaro R Kalviainen E Kaukanen E Mervaala E Ruokonen 2002 High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit Neurology 59 8 1249 1251 1:CAS:528:DC%2BD38Xns1Snsrk%3D 10.1001/archneur.59.8.1249 12391357 (Pubitemid 34856377)
24. I Parviainen A Uusaro R Kalviainen E Mervaala E Ruokonen 2006 Propofol in the treatment of refractory status epilepticus Intensive Care Med 32 7 1075 1079 1:CAS:528:DC%2BD1cXhtVOkur7M 10.1007/s00134-006-0154-1 16791671 (Pubitemid 43952725)
25. HG Kress R Segmuller 1987 Intravenous anesthetics and human neutrophil granulocyte motility in vitro Anaesthesist 36 7 356 361 1:CAS:528: DyaL2sXmtFWrsLg%3D 2889393
26. VN Iyer R Hoel AA Rabinstein 2009 Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience Crit Care Med 37 12 3024 3030 1:CAS:528:DC%2BD1MXhsValurbI 10.1097/CCM.0b013e3181b08ac7 19661801